Sign In

Login

Password

Forgot Password ? Sign Up

Remimazolam (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Remimazolam" in English language version.

refsWebsite
Global rank English rank
9nih.gov
4th place
4th place
7doi.org
2nd place
2nd place
5semanticscholar.org
11th place
8th place
3europa.eu
68th place
117th place
2fda.gov
447th place
338th place
1cosmopharma.com
low place
low place
1marketwired.com
low place
6,052nd place
1espacenet.com
800th place
676th place

cosmopharma.com

doi.org

espacenet.com

worldwide.espacenet.com

  • US 7473689, Feldman PL, Jung DK, Kaldor I, Pacofsky JG, Stafford JA, Tidwell JH, "Short-acting benzodiazepines", published 2009-01-06, assigned to CeNes Ltd. 

europa.eu

ema.europa.eu

  • "Byfavo EPAR". European Medicines Agency (EMA). 9 December 2020. Retrieved 20 April 2021. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  • "Byfavo: Pending EC decision". European Medicines Agency. 29 January 2021. Retrieved 25 February 2021. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

ec.europa.eu

fda.gov

fda.gov

accessdata.fda.gov

marketwired.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, et al. (July 2007). "CNS 7056: a novel ultra-short-acting Benzodiazepine". Anesthesiology. 107 (1): 60–66. doi:10.1097/01.anes.0000267503.85085.c0. PMID 17585216. S2CID 19504961.
  • Rogers WK, McDowell TS (December 2010). "Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures". IDrugs. 13 (12): 929–937. PMID 21154153.
  • Saari TI, Uusi-Oukari M, Ahonen J, Olkkola KT (March 2011). "Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology". Pharmacological Reviews. 63 (1): 243–267. doi:10.1124/pr.110.002717. PMID 21245208. S2CID 930379.
  • Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM (August 2012). "A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics". Anesthesia and Analgesia. 115 (2): 274–283. doi:10.1213/ANE.0b013e31823f0c28. PMID 22190555. S2CID 21457057.
  • Worthington MT, Antonik LJ, Goldwater DR, Lees JP, Wilhelm-Ogunbiyi K, Borkett KM, Mitchell MC (November 2013). "A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy". Anesthesia and Analgesia. 117 (5): 1093–1100. doi:10.1213/ANE.0b013e3182a705ae. PMID 24108261. S2CID 24581168.
  • Borkett KM, Riff DS, Schwartz HI, Winkle PJ, Pambianco DJ, Lees JP, Wilhelm-Ogunbiyi K (April 2015). "A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy". Anesthesia and Analgesia. 120 (4): 771–780. doi:10.1213/ANE.0000000000000548. PMID 25502841. S2CID 20941788.
  • Stafford JA, Pacofsky GJ, Cox RF, Cowan JR, Dorsey GF, Gonzales SS, et al. (November 2002). "Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonists". Bioorganic & Medicinal Chemistry Letters. 12 (21): 3215–3218. doi:10.1016/s0960-894x(02)00512-7. PMID 12372537.
  • Pacofsky GJ, Stafford JA, Cox RF, Cowan JR, Dorsey GF, Gonzales SS, et al. (November 2002). "Relating the structure, activity, and physical properties of ultrashort-acting benzodiazepine receptor agonists". Bioorganic & Medicinal Chemistry Letters. 12 (21): 3219–3222. doi:10.1016/s0960-894x(02)00513-9. PMID 12372538.

dailymed.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org